Semaglutide and Tirzepatide: Exploring the Benefits Beyond Diabetes and Weight Loss
Stefani Hillin2024-05-31T07:06:37+00:00Semaglutide and Tirzepatide have gained significant attention in the medical community primarily for their effectiveness in managing type 2 diabetes and facilitating weight loss. However, these medications, classified as GLP-1 receptor agonists (for Semaglutide) and dual GLP-1/GIP receptor agonists (for Tirzepatide), are now being explored for a variety of other potential health benefits beyond [...]